Central America vs Ghana: Proportion of the target population who received a 3rd dose of
Central America
80.0%
in 2024
Ghana
96.0%
in 2024
Central America rank
13th
Ghana rank
16th
Proportion of the target population who received a 3rd dose of over time
- Central America
- Ghana
How they compare
Ghana currently reports 96.0% against 80.0% in Central America, a difference of 16.0%.
That makes Ghana's figure about 1.2 times Central America's.
The two have swapped places 3 times across 13 shared years of data; in 2012 it was Central America ahead.
Central America ranks 13th and Ghana ranks 16th of 37 groups.
Across the 2 decades both report, Central America averaged higher in 1 and Ghana in 1.
Head to head by decade
| Decade | Central America | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 89.2% | 88.0% | 1.2% | Central America |
| 2020s | 81.4% | 96.8% | 15.4% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Central America or Ghana?
- Ghana, at 96.0% against 80.0% in Central America as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Central America and Ghana?
- 16.0%, with Ghana ahead.
- How many years of comparable data are there for Central America and Ghana?
- 13 years are reported by both, from 2012 to 2024.
- How do Central America and Ghana rank globally for proportion of the target population who received a 3rd dose of?
- Central America ranks 13th and Ghana ranks 16th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.